QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
NASDAQ:IRMD

IRadimed - IRMD Stock Forecast, Price & News

$38.58
+0.55 (+1.45%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$37.30
$38.92
50-Day Range
$30.52
$42.14
52-Week Range
$26.00
$55.92
Volume
45,435 shs
Average Volume
43,532 shs
Market Capitalization
$485.79 million
P/E Ratio
37.83
Dividend Yield
N/A
Price Target
$48.00

IRadimed MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
24.4% Upside
$48.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-0.85
Upright™ Environmental Score
News Sentiment
0.21mentions of IRadimed in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$2.06 M Sold Last Quarter
Proj. Earnings Growth
17.09%
From $1.17 to $1.37 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.15 out of 5 stars

Medical Sector

165th out of 995 stocks

Surgical & Medical Instruments Industry

13th out of 103 stocks


IRMD stock logo

About IRadimed (NASDAQ:IRMD) Stock

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Receive IRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRadimed and its competitors with MarketBeat's FREE daily newsletter.

IRMD Stock News Headlines

Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
IRadimed (IRMD) Q4 Earnings Top Estimates
IRadimed Third Quarter 2022 Earnings: Beats Expectations
3 REITs With Dividends Above 8% - Yahoo Finance
See More Headlines
Receive IRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRadimed and its competitors with MarketBeat's FREE daily newsletter.

IRMD Company Calendar

Last Earnings
2/02/2023
Ex-Dividend for 2/21 Dividend
2/10/2023
Dividend Payable
2/21/2023
Today
3/27/2023
Next Earnings (Estimated)
5/05/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IRMD
Employees
110
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$48.00
High Stock Price Forecast
$48.00
Low Stock Price Forecast
$48.00
Forecasted Upside/Downside
+26.7%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$12.83 million
Pretax Margin
30.36%

Debt

Sales & Book Value

Annual Sales
$53.30 million
Cash Flow
$1.07 per share
Book Value
$5.86 per share

Miscellaneous

Free Float
7,090,000
Market Cap
$476.91 million
Optionable
Not Optionable
Beta
1.03

Key Executives

  • Roger Susi
    Chairman, President & Chief Executive Officer
  • John F. Glenn
    Chief Financial Officer & Secretary
  • Chris Williamson
    Vice President-Information Technology
  • Lynn Neuhardt
    Vice President-Research & Development
  • Randy Waddell
    VP-Worldwide Sales & Marketing













IRMD Stock - Frequently Asked Questions

What is IRadimed's stock price forecast for 2023?

0 analysts have issued 12 month target prices for IRadimed's stock. Their IRMD share price forecasts range from $48.00 to $48.00. On average, they anticipate the company's share price to reach $48.00 in the next twelve months. This suggests a possible upside of 26.7% from the stock's current price.
View analysts price targets for IRMD
or view top-rated stocks among Wall Street analysts.

How have IRMD shares performed in 2023?

IRadimed's stock was trading at $28.29 on January 1st, 2023. Since then, IRMD stock has increased by 33.9% and is now trading at $37.88.
View the best growth stocks for 2023 here
.

When is IRadimed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 5th 2023.
View our IRMD earnings forecast
.

How were IRadimed's earnings last quarter?

IRadimed Co. (NASDAQ:IRMD) announced its earnings results on Thursday, February, 2nd. The medical equipment provider reported $0.29 earnings per share for the quarter, hitting the consensus estimate of $0.29. The medical equipment provider earned $14.86 million during the quarter, compared to analysts' expectations of $14.93 million. IRadimed had a trailing twelve-month return on equity of 18.81% and a net margin of 23.99%.

How often does IRadimed pay dividends? What is the dividend yield for IRadimed?

IRadimed announced a dividend on Monday, February 6th. Investors of record on Monday, February 13th will be paid a dividend of $1.05 per share on Tuesday, February 21st. This represents a dividend yield of 2.54%. The ex-dividend date of this dividend is Friday, February 10th. This is an increase from the stock's previous dividend of $1.00.
Read our dividend analysis for IRMD
.

What ETF holds IRadimed's stock ?

Ballast Small/Mid Cap ETF holds 16,660 shares of IRMD stock, representing 0.91% of its portfolio.

What guidance has IRadimed issued on next quarter's earnings?

IRadimed updated its fourth quarter 2022 earnings guidance on Wednesday, January, 18th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $14.90 million-$14.90 million, compared to the consensus revenue estimate of $14.63 million.

What other stocks do shareholders of IRadimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IRadimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Alphabet (GOOG), Mastercard (MA), Micron Technology (MU), PayPal (PYPL), CRISPR Therapeutics (CRSP), IntriCon (IIN), QUALCOMM (QCOM) and Twitter (TWTR).

What is IRadimed's stock symbol?

IRadimed trades on the NASDAQ under the ticker symbol "IRMD."

Who are IRadimed's major shareholders?

IRadimed's stock is owned by a variety of institutional and retail investors. Top institutional investors include Soleus Capital Management L.P. (5.93%), Renaissance Technologies LLC (4.73%), Bares Capital Management Inc. (2.16%), Russell Investments Group Ltd. (1.61%), Dimensional Fund Advisors LP (1.28%) and Geode Capital Management LLC (1.07%). Insiders that own company stock include Anthony Vuoto, Brent Johnson, Christopher K Scott, James B Hawkins, Monty K Allen, Monty K Allen and Roger E Susi.
View institutional ownership trends
.

How do I buy shares of IRadimed?

Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IRadimed's stock price today?

One share of IRMD stock can currently be purchased for approximately $37.88.

How much money does IRadimed make?

IRadimed (NASDAQ:IRMD) has a market capitalization of $476.91 million and generates $53.30 million in revenue each year. The medical equipment provider earns $12.83 million in net income (profit) each year or $1.02 on an earnings per share basis.

How many employees does IRadimed have?

The company employs 110 workers across the globe.

How can I contact IRadimed?

IRadimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The official website for the company is www.iradimed.com. The medical equipment provider can be reached via phone at (407) 677-8022, via email at investorrelations@iradimed.com, or via fax at 407-677-5037.

This page (NASDAQ:IRMD) was last updated on 3/27/2023 by MarketBeat.com Staff